Profile data is unavailable for this security.
About the company
Sipai Health Technology Co Ltd is principally engaged in providing medical and health services. The Company’s businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.
- Revenue in HKD (TTM)4.99bn
- Net income in HKD-259.89m
- Incorporated2015
- Employees3.25k
- LocationSipai Health Technology Co, LtdGUANGZHOU ChinaCHN
- Websitehttp://www.medbankshealthtech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dingdang Health Technology Group Ltd | 5.25bn | -212.65m | 804.88m | 2.51k | -- | 0.3847 | -- | 0.1534 | -0.1599 | -0.1599 | 3.95 | 1.56 | 1.57 | 5.61 | 43.27 | 2,005,960.00 | -6.53 | -55.91 | -9.42 | -82.51 | 32.38 | 32.74 | -4.17 | -35.83 | 1.86 | -- | 0.0766 | -- | 12.19 | 52.72 | 92.03 | -- | 13.40 | -- |
| Sunshine Holdings PLC | 1.50bn | 119.60m | 936.51m | 1.70k | 7.83 | 1.89 | 5.13 | 0.6237 | 9.13 | 9.13 | 114.65 | 37.82 | 1.33 | 3.45 | 5.04 | 33,119,650.00 | 14.05 | 12.87 | 27.34 | 23.74 | 30.87 | 29.69 | 10.58 | 10.29 | 1.01 | 20.22 | 0.274 | 16.93 | 7.03 | 19.65 | 97.49 | 47.20 | -5.69 | 48.41 |
| Charmacy Pharmaceutical Co Ltd | 4.82bn | 55.64m | 1.00bn | 834.00 | 18.05 | 1.58 | 11.51 | 0.2084 | 0.5153 | 0.5153 | 44.63 | 5.90 | 1.47 | 5.49 | 4.76 | 5,800,294.00 | 1.70 | 1.79 | 8.48 | 7.99 | 6.91 | 6.16 | 1.15 | 1.24 | 0.7714 | 2.44 | 0.5882 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
| Kimia Farma Tbk PT | 4.99bn | -843.72m | 1.70bn | 10.71k | -- | 0.6474 | -- | 0.3412 | -307.59 | -311.08 | 1,817.52 | 957.72 | 0.5415 | 2.78 | 4.36 | 882,472,800.00 | -11.90 | -1.82 | -23.42 | -3.22 | 24.05 | 35.14 | -21.98 | -3.08 | 0.4154 | -3.76 | 0.5702 | -- | 7.93 | 3.33 | -737.71 | -- | -9.87 | -- |
| Sipai Health Technology Co, Ltd | 4.99bn | -259.89m | 3.98bn | 3.25k | -- | 2.47 | -- | 0.7974 | -0.3309 | -0.3309 | 6.56 | 2.11 | 1.58 | 13.61 | 9.78 | 1,611,118.00 | -7.98 | -- | -13.82 | -- | 9.18 | -- | -5.05 | -- | 1.58 | -- | 0.0386 | -- | 14.39 | -- | 81.34 | -- | -- | -- |
| JZJ Chain Drugstore Corp | 10.03bn | 255.00m | 4.72bn | 16.65k | 18.27 | 1.58 | -- | 0.4708 | 1.53 | 1.53 | 60.20 | 17.72 | 0.9258 | 2.20 | 20.72 | 559,572.20 | 2.34 | 5.75 | 4.50 | 11.17 | 35.54 | 35.21 | 2.53 | 5.04 | 0.2655 | 2.88 | 0.6563 | 36.62 | 20.84 | 26.84 | 10.72 | 25.41 | 23.62 | -- |
| Genky DrugStores Co Ltd | 9.41bn | 323.52m | 4.76bn | 1.66k | 14.45 | 1.94 | 7.82 | 0.5060 | 212.46 | 212.46 | 6,180.37 | 1,582.20 | 1.67 | 6.47 | 43.31 | 113,208,300.00 | 5.76 | 4.94 | 8.65 | 7.86 | 20.41 | 20.67 | 3.44 | 2.98 | 0.4102 | 59.82 | 0.4195 | 8.24 | 9.35 | 12.21 | 32.75 | 18.58 | -0.5316 | 0.3968 |
| MedPlus Health Services Ltd | 5.53bn | 92.37m | 7.53bn | 21.00k | 81.70 | 4.99 | 24.03 | 1.36 | 8.37 | 8.37 | 500.31 | 136.89 | 1.97 | 3.55 | 447.43 | 2,855,699.00 | 3.29 | 2.68 | 4.02 | 3.48 | 22.66 | 21.14 | 1.67 | 1.38 | 0.6598 | 1.77 | 0.3863 | 0.00 | 23.42 | 19.87 | 31.57 | 40.59 | 31.14 | -- |
| Fangzhou Inc | 2.65bn | -926.66m | 8.90bn | 515.00 | -- | -- | -- | 3.36 | -0.6914 | -0.6914 | 1.98 | -1.60 | -- | -- | -- | 5,150,034.00 | -- | -- | -- | -- | 20.52 | -- | -34.94 | -- | 0.699 | -- | 30.75 | -- | 10.43 | -- | 48.66 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 3.56m | 0.47% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 507.20k | 0.07% |
| BlackRock Advisors (UK) Ltd.as of 03 Oct 2024 | 222.00k | 0.03% |
| TIAA-CREF Investment Management LLCas of 31 Aug 2024 | 197.60k | 0.03% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 166.60k | 0.02% |
| State Street Global Advisors Ltd.as of 02 Oct 2024 | 54.60k | 0.01% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2024 | 16.40k | 0.00% |
| Geode Capital Management LLCas of 30 Sep 2024 | 7.80k | 0.00% |
| Hang Seng Investment Management Ltd.as of 30 Jun 2024 | 1.40k | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 0.00 | 0.00% |
